Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,660 | 302 | 99.7% |
| Education | $13.89 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $700.95 | 49 | $0 (2024) |
| ABBVIE INC. | $686.65 | 44 | $0 (2024) |
| Amgen Inc. | $326.86 | 18 | $0 (2024) |
| Lilly USA, LLC | $315.82 | 20 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $248.04 | 14 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $199.84 | 14 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $170.57 | 11 | $0 (2022) |
| Allergan, Inc. | $148.05 | 8 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $138.78 | 8 | $0 (2022) |
| Abbott Laboratories | $117.56 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $520.32 | 32 | Novo Nordisk Inc ($203.83) |
| 2023 | $587.41 | 36 | Novo Nordisk Inc ($141.66) |
| 2022 | $1,413 | 90 | ABBVIE INC. ($332.22) |
| 2021 | $473.63 | 33 | AbbVie Inc. ($174.97) |
| 2020 | $286.03 | 18 | Allergan, Inc. ($83.72) |
| 2019 | $735.66 | 52 | Sunovion Pharmaceuticals Inc. ($183.43) |
| 2018 | $271.82 | 20 | Novo Nordisk Inc ($54.95) |
| 2017 | $386.88 | 22 | Amgen Inc. ($127.41) |
All Payment Transactions
303 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.28 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $11.92 | General |
| 09/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Biological | ||||||
| 09/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.65 | General |
| 07/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Bone Health | ||||||
| 07/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.40 | General |
| 06/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Neurology | ||||||
| 05/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Cardio-renal | ||||||
| 04/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.04 | General |
| 04/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.77 | General |
| 04/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Diabetes | ||||||
| 02/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 90 | 111 | $7,824 | $2,588 |
| 2022 | 3 | 86 | 133 | $15,188 | $5,480 |
| 2021 | 3 | 88 | 122 | $14,589 | $5,452 |
| 2020 | 4 | 95 | 123 | $14,230 | $5,642 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 18 | 19 | $2,779 | $1,142 | 41.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 29 | $2,449 | $1,067 | 43.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 56 | 63 | $2,596 | $378.20 | 14.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 33 | 77 | $6,503 | $2,049 | 31.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 29 | 32 | $4,680 | $1,718 | 36.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 24 | 24 | $4,005 | $1,713 | 42.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 29 | 31 | $5,173 | $2,278 | 44.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 31 | 63 | $5,321 | $1,753 | 32.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 28 | 28 | $4,095 | $1,422 | 34.7% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 30 | 32 | $5,340 | $2,472 | 46.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 29 | 30 | $4,388 | $1,682 | 38.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 24 | 46 | $3,885 | $1,389 | 35.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 12 | 15 | $618.00 | $98.95 | 16.0% |
About Dr. Jon Sides, M.D
Dr. Jon Sides, M.D is a Family Medicine healthcare provider based in Burlington, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912901885.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jon Sides, M.D has received a total of $4,674 in payments from pharmaceutical and medical device companies, with $520.32 received in 2024. These payments were reported across 303 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($4,660).
As a Medicare-enrolled provider, Sides has provided services to 359 Medicare beneficiaries, totaling 489 services with total Medicare billing of $19,161. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Burlington, KS
- Active Since 06/09/2005
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1912901885
Products in Payments
- VRAYLAR (Drug) $344.76
- Ozempic (Drug) $327.80
- UBRELVY (Drug) $312.89
- Rybelsus (Drug) $217.85
- REXULTI (Drug) $210.32
- LONHALA MAGNAIR (Drug) $183.43
- MOUNJARO (Drug) $156.71
- NURTEC ODT (Drug) $153.18
- TRULICITY (Drug) $131.85
- ELIQUIS (Drug) $127.15
- XARELTO (Drug) $121.43
- FREESTYLE LIBRE 2 (Device) $117.56
- Prolia (Biological) $103.12
- QULIPTA (Drug) $99.23
- TROKENDI XR (Drug) $93.63
- EVENITY (Biological) $86.76
- Prolastin-C Liquid (Biological) $85.23
- ABILIFY MAINTENA (Drug) $80.94
- CAPLYTA (Drug) $80.84
- XIFAXAN (Drug) $74.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Burlington
Krichna Sowles, Md, MD
Family Medicine — Payments: $17,218
Dr. Jasmine Bajaj, Md, MD
Family Medicine — Payments: $8,590
Dr. Richard Gilbert, Md, MD
Family Medicine — Payments: $7,905
Michol Negron, D.o, D.O
Family Medicine — Payments: $7,588
Dr. Donald Fisher, Md, MD
Family Medicine — Payments: $7,370
Christopher Jarvis, M.d, M.D
Family Medicine — Payments: $5,691